Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

RPS6KA3

RBC: RSK2 · Substrate: Glycogen Synthase-derived peptide ·

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Midostaurin95.80.50
Brigatinib95.20.51
Netarsudil89.10.68
Rabusertib76.20.69
Capivasertib75.20.64
Sunitinib54.10.52
Ceritinib52.00.62
Defactinib50.40.45
Gilteritinib38.80.51
Darovasertib30.80.72
Nintedanib29.50.61
Bosutinib27.80.55
Alectinib25.30.65
Axitinib23.00.69
Ponatinib22.70.53

Known variants

No variants catalogued.
Open in new tab